Skip to content

EPS (Diluted) at other companies

AMN Healthcare logo
AMN HealthcareAMN
$1.59+5,400%
Teladoc Health logo
Teladoc HealthTDOC
-$0.36+32.1%
Cencora logo
CencoraCOR
$8.40+128%
Option Care Health, Inc. logo
Option Care Health, Inc.OPCH
$0.29+3.6%
Viemed Healthcare, Inc. logo
Viemed Healthcare, Inc.VMD
$0.060.0%
Concentra Group Holdings Parent logo
Concentra Group Holdings ParentCON
$0.39+30.0%

Other financials

Income statement

See full
Revenue$241.1M-17.8%
Operating income-$4.2M-325%
Net income-$4.3M-771%

Balance sheet

See full
Cash & equivalents$105.6M+30.8%
Total debt$2.0M-38.3%
Total equity$312.8M-25.2%
Total assets$451.1M-21.7%

Cash flow

See full
Operating cash flow$4.8M-16.1%
CapEx$1.5M-22.7%
Free cash flow$3.3M-12.8%

Valuation

See full
Market cap$426.12M-6.5%
Enterprise value$322.58M-14.7%
P/S0.4×+0.1×

Profitability

See full
Operating margin-8.7%-11.4pp
Net margin-9.8%-11.8pp
FCF margin4%-4.9pp

Returns & leverage

See full
Return on equity-27%-32.7pp
Debt / equity0.0×
Current ratio3.3×+0.3×

Where this comes from

Reported directly by Cross Country Healthcare in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: Cross Country Healthcare’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cross Country Healthcare's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cross Country Healthcare's EPS (diluted)?
Cross Country Healthcare (CCRN) reported EPS (diluted) of -$0.14 in Q1 2026.
How has Cross Country Healthcare's EPS (diluted) changed year-over-year?
Cross Country Healthcare's EPS (diluted) decreased by 600.0% year-over-year, from -$0.02 to -$0.14.
What is the long-term trend for Cross Country Healthcare's EPS (diluted)?
Over 4 years (2021 to 2025), Cross Country Healthcare's EPS (diluted) has grown at a -4.6% compound annual growth rate (CAGR), from $3.53 to -$2.93.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.